Compare · NH vs PDD
NH vs PDD
Side-by-side comparison of NantHealth Inc. (NH) and PDD Holdings Inc. (PDD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NH and PDD operate in EDP Services (Technology), so they compete in similar markets.
- PDD is the larger of the two at $110.64B, about 1244.7x NH ($88.9M).
- PDD has been more active in the news (5 items in the past 4 weeks vs 1 for NH).
- PDD has more recent analyst coverage (25 ratings vs 0 for NH).
- Company
- NantHealth Inc.
- PDD Holdings Inc.
- Price
- $1.96-32.41%
- $77.71-1.33%
- Market cap
- $88.9M
- $110.64B
- 1M return
- -
- -10.95%
- 1Y return
- -
- -41.55%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2018
- News (4w)
- 1
- 5
- Recent ratings
- 0
- 25
NantHealth Inc.
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
PDD Holdings Inc.
Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverage, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.
Latest NH
- PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors
- SEC Form 15-12G filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Leadership Update
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
Latest PDD
- PDD Holdings downgraded by Arete with a new price target
- Director Kam Anthony Ping Leung sold $140,151 worth of ADSs (1,705 units at $82.20), closing all direct ownership in the company (SEC Form 4)
- Director Kam Anthony Ping Leung converted options into 1,705 units of ADSs (SEC Form 4)
- SEC Form 6-K filed by PDD Holdings Inc.
- PDD Holdings Announces Second Quarter 2026 Unaudited Financial Results
- SEC Form 6-K filed by PDD Holdings Inc.
- PDD Holdings to Report Second Quarter 2026 Unaudited Financial Results on August 24, 2026
- Director Yeo George Yong-Boon converted options into 1,584 units of ADSs, increasing direct ownership by 6% to 27,212 units (SEC Form 4)
- SEC Form 4 filed by Co-Chief Executive Officer Zhao Jiazhen
- SEC Form 4 filed by SVP of Engineering Wang Mi